Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × Etoposide × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 117 Lymphoma, Large B-Cell, Diffuse 76 Lymphoma, Non-Hodgkin 73 Small Cell Lung Carcinoma 63 Hodgkin Disease 56 Precursor Cell Lymphoblastic Leukemia-Lymphoma 52 Burkitt Lymphoma 52 Leukemia 51 Lymphoma, Follicular 42 Lung Neoplasms 40 Lymphoma, Large-Cell, Immunoblastic 38 Lymphoma, Mantle-Cell 37 Leukemia, Myeloid, Acute 36 Leukemia, Lymphocytic, Chronic, B-Cell 32 Multiple Myeloma 28 Carcinoma, Non-Small-Cell Lung 25 Lymphoma, B-Cell, Marginal Zone 24 Recurrence 23 Central Nervous System Neoplasms 20 Neuroblastoma 19 Ovarian Neoplasms 17 Dendritic Cell Sarcoma, Interdigitating 16 Sarcoma 15 Breast Neoplasms 15 Neoplasms, Plasma Cell 14 Congenital Abnormalities 14 Brain Neoplasms 14 Myelodysplastic Syndromes 12 Lymphoma, Large-Cell, Anaplastic 12 Testicular Neoplasms 11

Interventions

Carboplatin 46 Paclitaxel 41 Bevacizumab 30 Gemcitabine 15 pembrolizumab 14 Taxes 11 Cisplatin 11 olaparib 10 Immunoglobulin G 10 Disulfides 10 Topotecan 9 Cyclophosphamide 7 niraparib 6 Specimen Handling 6 Biopsy 6 Nivolumab 5 Drug Therapy 5 Cytoreduction Surgical Procedures 5 oregovomab 4 mirvetuximab soravtansine 4 liposomal doxorubicin 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Letrozole 4 Hyperthermic Intraperitoneal Chemotherapy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 sargramostim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01669226 2016-12-19

AICE

Shanghai Gynecologic Oncology Group

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡